4
Changes in Ownership
InMed Pharmaceuticals Inc. Filed Acc 0001213900-20-043371
Options or other derivatives
- Director acquired 18,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sazdanoff Catherine · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-16 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +7,000 | 7,000 | D |
| 2020-12-16 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +11,000 | 11,000 | D |
Loading xslF345X03/ownership.xml…